Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
4,158.24
+103.12
(
+2.48%
)
Dow 30
+1.74%
QQQ
+3.31%
VIX
25.72
-1.78
(
-6.47%
)
Cullinan Oncology Inc
NASDAQ:CGEM
11.47
+0.91
(
+8.62%
)
Mergers / Acquisitions
Cullinan And Taiho To Jointly Develop And Commercialize Cln-081/Tas6417 And Taiho's Acquisition Of Cullinan Pearl
Published: 05/12/2022 06:14 GMT
CGEM
Cullinan Oncology Inc (
CGEM
)
- Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize Cln-081/tas6417 and Taiho's Acquisition of Cullinan Pearl.